Second Affiliated Hospital, Zhejiang University, School of Medicine

Academic

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Nov 5, 2026

Active, not recruiting

Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）：A Prospective, Randomized, Open-Label, Multi-Center Phase 3 Trial

Nov 5, 2026

Recruiting

A Prospective Cohort Study Exploring the Safety and the Efficiency of Hyperbaric Oxygen in Treating Traumatic Brain Injury During Nonacute Phrase

Nov 5, 2026

Completed

Nutrition-Optimized Prehabilitation's Impact on Perioperative Outcomes in Primary Liver Carcinoma: A Randomized Controlled Trial

Nov 4, 2026

Completed

Retrospective Analysis of Erectile Dysfunction (ED) Patients Based on a Large-scale Clinical Database

Oct 30, 2026

Recruiting

A Prospective Cohort Study of Emotion-Related Disorders

Earlier

Oct 22, 2026TrialTranscatheter Aortic Valve Replacement For Patients With Bicuspid Aortic Stenosis (Type 0) Using Down Sizing Strategy Compared With Standard Sizing Strategy (HANGZHOU Solution): A Prospective, Multicenter, Randomized Controlled Trial

Oct 21, 2026TrialLow- Versus High-Energy Electrical Cardioversion for Atrial Fibrillation: A Clinical Outcome ComparisonEnergy Dose and Cardioversion Outcomes in AF

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)